Guidelines : Inflammatory bowel disease
Detail
Condition :
Inflammatory bowel disease
Keywords :
IBD, CD, Chronic Bowel Disorder, inflammatory bowel disease, corticosteroid, 5-ASA, aminosalicylate, UC, ulcerative Colitis, prednisolone, mesalazine, crohns, lower GI symptoms, Crohn's, Crohn's disease
Committee Recommendations
Date
Committee Name
Narrative
Traffic Light Status
01 March 2023
The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed the reviewed and updated IBD immunomodulator pathway.
N/A
06 November 2019
The Surrey & North West Sussex Area Prescribing Committee recommend the use of an online toolkit to support prescribers when a patient presents with symptoms of IBD. The toolkit has been developed by the Royal College of Practitioners (RCGP) and Crohn's & Colitis UK. Follow this link to the toolkit https://www.rcgp.org.uk/ibd
N/A
Documents
Type
Document
Review Date
Guidelines (Local)
December 2021
Guidelines (Local)
December 2021
Supplementary documents (CCG specific documents)
No records returned.
Drugs
Below are listed drugs that are used to treat Inflammatory bowel disease.
- Allopurinol Amber
- Prednisolone (Oral) Green